Chris Koopmans - Dec 15, 2023 Form 4 Insider Report for Marvell Technology, Inc. (MRVL)

Signature
Christopher Koopmans by Blair Walters as Attorney-in-Fact
Stock symbol
MRVL
Transactions as of
Dec 15, 2023
Transactions value $
-$297,850
Form type
4
Date filed
12/18/2023, 11:19 AM
Previous filing
Nov 16, 2023
Next filing
Jan 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVL Common Stock Sale -$298K -5K -3.86% $59.57 124K Dec 15, 2023 By Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on 07/14/2023.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.15 to $60.05, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.